VDR agonists bind VDR
VDR + VDR agonists → VDR:VDR agonists
- Reactome
- R-HSA-9660192
- Compartment
- nucleoplasm
- Rhea
- None recorded
Inputs
- VDRR-HSA-375512, nucleoplasm
- VDR agonistsR-ALL-9660116, nucleoplasm
Outputs
- VDR:VDR agonistsR-HSA-9660135, nucleoplasm
Literature
- Active vitamin D analogs, maxacalcitol and alfacalcidol, as maintenance therapy for mild secondary hyperparathyroidism in hemodialysis patients - a randomized study Int J Clin Pharmacol Ther, 2014
- Comparative efficacy and safety of paricalcitol versus vitamin D receptor activators for dialysis patients with secondary hyperparathyroidism: a meta-analysis of randomized controlled trials BMC Nephrol, 2017
- Comparison between paricalcitol and active non-selective vitamin D receptor activator for secondary hyperparathyroidism in chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials Int Urol Nephrol, 2016
- Comparison of oral falecalcitriol and intravenous calcitriol in hemodialysis patients with secondary hyperparathyroidism: a randomized, crossover trial Clin. Nephrol., 2009
- Comparison of paricalcitol with maxacalcitol injection in Japanese hemodialysis patients with secondary hyperparathyroidism Ther Apher Dial, 2015
- Double-blind, placebo-controlled, randomized, right-left study comparing calcipotriol monotherapy with a combined treatment of calcipotriol and diflucortolone valerate in chronic plaque psoriasis Acta Derm Venereol Suppl (Stockh), 2000